Quick Answer
VivoSim Labs, INC. reported Total Revenue of $144.0 thousand for fiscal year 2025.
VivoSim Labs, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $144.0K +32.1% |
$109.0K -70.5% |
$370.0K -75.3% |
$1.50M | $0.00 -100.0% |
$2.20M -29.0% |
| Revenue (ASC 606) | $144.0K +32.1% |
$109.0K -70.5% |
$370.0K -75.3% |
$1.50M | $0.00 -100.0% |
$2.20M -29.0% |
| Net Income | -$2.49M +83.0% |
-$14.67M +15.0% |
-$17.26M -50.8% |
-$11.45M +32.0% |
-$16.83M +10.1% |
-$18.71M +29.8% |
| Diluted EPS | -$1.70 +91.2% |
-$19.25 -872.2% |
-$1.98 -50.0% |
-$1.32 | — | — |
| Total Assets | $14.65M +130.7% |
$6.35M -68.7% |
$20.31M -39.0% |
$33.30M -16.6% |
$39.92M +40.4% |
$28.44M -30.0% |
| Cash and Equivalents | $11.31M +289.9% |
$2.90M -81.0% |
$15.30M -46.6% |
$28.68M -23.3% |
$37.36M +36.6% |
$27.36M -25.0% |
| Stockholders Equity | $10.49M +191.4% |
$3.60M -76.5% |
$15.33M -49.3% |
$30.21M -22.9% |
$39.20M +47.2% |
$26.63M -26.6% |
| R&D Expense | $5.03M -8.6% |
$5.50M -38.1% |
$8.88M +167.6% |
$3.32M +201.0% |
$1.10M -79.1% |
$5.28M -64.2% |
| Operating Income | -$12.62M +16.4% |
-$15.09M +14.9% |
-$17.73M -54.5% |
-$11.48M +31.8% |
-$16.83M +21.6% |
-$21.48M +21.3% |
| Shares Outstanding | 1.90M +126.0% |
839,814 -90.4% |
8.72M +0.1% |
8.71M +0.5% |
8.67M +32.8% |
6.53M -94.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $26.0K | +8.3% | -7.1% |
| Revenue (ASC 606) | December 31, 2025 | $26.0K | +8.3% | -7.1% |
| Net Income | December 31, 2025 | -$2.69M | +21.9% | -5.7% |
| Diluted EPS | December 31, 2025 | -$1.03 | +54.8% | -5.1% |
| Total Assets | December 31, 2025 | $6.96M | +81.1% | -28.1% |
| Cash and Equivalents | December 31, 2025 | $4.29M | +269.3% | -35.8% |
| Stockholders Equity | December 31, 2025 | $4.44M | +1120.1% | -37.1% |
| R&D Expense | December 31, 2025 | $1.14M | -36.0% | +23.5% |
| Operating Income | December 31, 2025 | -$2.75M | +20.7% | -4.4% |
| Shares Outstanding | December 31, 2025 | 2.61M | -84.8% | +0.0% |
- VivoSim Labs, INC. reported Total Revenue of $144.0 thousand for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +32.1% in Total Revenue compared to the prior fiscal year.
- VivoSim Labs, INC. reported Revenue (ASC 606) of $144.0 thousand for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +32.1% in Revenue (ASC 606) compared to the prior fiscal year.
- VivoSim Labs, INC. reported Net Income of -$2.49 million for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +83.0% in Net Income compared to the prior fiscal year.
- VivoSim Labs, INC. reported Diluted EPS of $1.70 per share (loss) for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +91.2% in Diluted EPS compared to the prior fiscal year.
- VivoSim Labs, INC. reported Total Assets of $14.65 million for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +130.7% in Total Assets compared to the prior fiscal year.
- VivoSim Labs, INC. reported Cash and Equivalents of $11.31 million for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +289.9% in Cash and Equivalents compared to the prior fiscal year.
- VivoSim Labs, INC. reported Stockholders Equity of $10.49 million for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +2782.4% in Stockholders Equity compared to the prior fiscal year.
- VivoSim Labs, INC. reported R&D Expense of $5.03 million for fiscal year 2025.
- VivoSim Labs, INC. showed a decrease of -8.6% in R&D Expense compared to the prior fiscal year.
- VivoSim Labs, INC. reported Operating Income of -$12.62 million for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +16.4% in Operating Income compared to the prior fiscal year.
- VivoSim Labs, INC. reported Shares Outstanding of 1.90 million shares for fiscal year 2025.
- VivoSim Labs, INC. showed an increase of +126.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: